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Dihydrotestosterone-Inducible IL-6 Inhibits
Elongation of Human Hair Shafts by Suppressing
Matrix Cell Proliferation and Promotes Regression
of Hair Follicles in Mice
Mi Hee Kwack1, Ji Sup Ahn2, Moon Kyu Kim1, Jung Chul Kim1 and Young Kwan Sung1
Autocrine and paracrine factors are produced by balding dermal papilla (DP) cells following dihydrotestoster-
one (DHT)-driven alterations and are believed to be key factors involved in male pattern baldness. Herein we
report that the IL-6 is upregulated in balding DP cells compared with non-balding DP cells. IL-6 was upregulated
3hours after 10–100 nM DHT treatment, and ELISA showed that IL-6 was secreted from balding DP cells in
response to DHT. IL-6 receptor (IL-6R) and glycoprotein 130 (gp130) were expressed in follicular keratinocytes,
including matrix cells. Recombinant human IL-6 (rhIL-6) inhibited hair shaft elongation and suppressed
proliferation of matrix cells in cultured human hair follicles. Moreover, rhIL-6 injection into the hypodermis
of mice during anagen caused premature onset of catagen. Taken together, our data strongly suggest that
DHT-inducible IL-6 inhibits hair growth as a paracrine mediator from the DP.
Journal of Investigative Dermatology (2012) 132, 43–49; doi:10.1038/jid.2011.274; published online 1 September 2011
INTRODUCTION
The hair follicle contains epithelial cell populations of outer
root sheath, matrix, and its derivatives—inner root sheath and
hair shaft. The hair follicle also contains dermal papilla (DP)
and dermal sheath (DS) cells derived from the mesenchyme.
The reciprocal interactions between the epithelium and
mesenchyme are essential for postnatal hair growth and
cycling of hair follicles (reviewed by Hardy, 1992; Millar,
2002; Botchkarev and Kishimoto, 2003). The postnatal hair
follicle undergoes a cycle of growth (anagen), regression
(catagen), and rest (telogen; reviewed by Stenn and Paus,
2001; Botchkarev and Kishimoto, 2003).
Male pattern baldness is the most common type of hair
loss in men (reviewed by Hoffmann, 2002; Rathnayake and
Sinclair, 2010). One of the key features of male pattern
baldness is follicular miniaturization, in which thick terminal
hairs are transformed into thin vellus-like hairs (Rushton
et al., 1991). In addition, in developing male pattern
baldness, hair follicles undergo premature transition from
anagen to catagen (reviewed by Jahoda, 1998; Kaufman,
2002); thus, hair follicles spend more time in telogen with a
short anagen phase, resulting in shorter hairs.
Dihydrotestosterone (DHT) dependence of male pattern
baldness has been well demonstrated (Imperato-McGinley
et al., 1974; Kuttenn et al., 1979; Drake et al., 1999).
Circulating androgens, including DHT, enter the follicle via
the DP capillaries. In addition, a significant portion of DHT is
produced by DP cells from testosterone. Androgens bind to
the androgen receptor within the DP cells and then activate
or repress target genes (Randall et al., 1994; reviewed by
Randall, 2008; Inui and Itami, 2011). Therefore, it is believed
that DP cells secrete diffusible factors that affect follicular
keratinocytes and DP cells in response to androgens.
In this study, we report that the IL-6 is upregulated in
balding DP cells compared with non-balding DP cells. We
showed that IL-6 is produced by balding DP cells in response
to DHT. In addition, we examined expression of IL-6
receptors in human hair follicles, investigated the effects of
IL-6 on cultured human hair follicles, and assessed the role
of recombinant human IL-6 (rhIL-6) in postnatal hair cycling
in mice.
RESULTS
Upregulation of IL-6 mRNA and protein in balding DP cells
In our preliminary experiments using an ELISA strip for
profiling angiogenesis proteins, we found higher levels of IL-6
in conditioned medium of balding DP cells compared with
non-balding DP cells (data not shown). To verify the
upregulation of IL-6 in balding DP cells, we therefore
examined the expression of IL-6 transcript by reverse
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transcription-PCR analysis using seven pairs of balding DP
cells and matched non-balding DP cells. Higher levels of IL-6
expression were observed in balding DP cells in six of seven
cases (Figure 1a). Next, we measured the concentration of
IL-6 in the conditioned medium produced by balding DP
cells and non-balding DP cells using ELISA. We found that all
of balding DP cells secrete higher levels of IL-6 compared
with matched non-balding DP cells (Figure 1b).
IL-6 induction in balding DP cells by DHT
We next examined whether or not IL-6 expression is affected
by DHT. As androgen receptor expression is downregulated
significantly in cultured balding DP cells (Kwack et al.,
2008), early-passage (p2–p3) DP cells were treated with
varying physiological concentrations of DHT or vehicle
control (ethanol). ELISA showed that IL-6 is secreted from
balding DP cells in response to DHT and maximum secretion
was observed in 100 nM DHT. The mean concentration of
IL-6 was 2,286 pgml1 in the presence of 100 nM DHT and
361pgml1 in the absence of DHT (Figure 1c). Reverse
transcription-PCR analysis showed that IL-6 is upregulated
after 10–100 nM DHT treatment and maximum induction was
observed at 100 nM DHT (Figure 1d). We also observed that
IL-6 is upregulated 3 hours after DHT treatment (Figure 1e).
IL-6R and gp130 is expressed in human follicular keratinocytes
To identify the target cells of IL-6 in human hair follicles, we
examined the expression of IL-6 receptor (IL-6R) and
glycoprotein 130 (gp130), a critical IL-6 family member
protein, in human hair follicles. We found that IL-6R and
gp130 are expressed in matrix cells, as well as the outer and
inner root sheaths of human scalp hair follicles (Figure 2a–f).
Immunoblot analysis also showed that IL-6R and gp130 are
expressed in cultured matrix cells and outer root sheath
keratinocytes (Figure 2g). Occasionally, we observed weak
expression of IL-6R and gp130 in the DP and DS of hair
follicles and in cultured DP and DS cells. When expression of
the IL-6R (Figure 3a–d) and gp130 (Figure 3e–h) in balding
versus non-balding hair follicles was examined, no significant
difference was observed.
IL-6 inhibits hair shaft elongation and proliferation of matrix
cells in cultured human hair follicles
We next investigated the effects of IL-6 on hair shaft
elongation using a hair follicle organ culture system (Philpott
et al., 1994). Isolated scalp hair follicles were cultured for 6
days in the presence or absence of rhIL-6. In this study, we
used 5–50 ngml1 of IL-6. Although we were not sure as to
whether these doses were physiologic, 25–100 ngml1 of IL-6
is commonly used in in vitro studies (Herna´ndez-Quintero
et al., 2006; Wang et al., 2007). We observed that hair shaft
elongation is inhibited by IL-6 treatment in a dose-dependent
manner. The average elongation of hair shafts after 6 days
was 1.96mm in the absence of IL-6, whereas 1.62 and
1.33mm in the presence of 5 and 50 ngml1 of rhIL-6,
respectively (Figure 4a). We also observed that the number of
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Figure 1. Upregulation of IL-6 in cultured balding DP cells compared with the non-balding DP cells and IL-6 induction in response to DHT in balding DP cells.
Seven pairs of matched balding and non-balding dermal papilla (DP) cells were analyzed by reverse transcription (RT)-PCR (a). IL-6 levels in conditioned
medium of balding (B) and non-balding (NB) DP cells from four matched pairs in duplicate measurements were made by ELISA and the relative fold change
of IL-6 in each cases (B/NB) are shown (b). Balding DP cells were treated with varying concentrations of dihydrotestosterone (DHT), and concentrations
of IL-6 were measured by ELISA (c); values represent the mean±SD of five experiments using five different DP cell strains and duplicate measurements
were made for each experiment (*Po0.005, **Po0.001). Cells were also treated with varying concentrations of DHT for 6 hours (d) or 100 nM DHT for
varying times (e) and analyzed by RT-PCR.
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Figure 2. Expression of IL-6R and gp130 in hair follicles and cultured cells. Human scalp hair follicles were immunostained with antibodies against IL-6
receptor (IL-6R, a) and glycoprotein 130 (gp130, b). High-powered images of IL-6R and gp130 expression in hair bulb regions are also shown in c and d,
respectively. Close-up images of boxed regions of c and d with emphasis on the follicular matrix are also shown in e and f. Bar¼ 0.1mm. Immunoblot analysis
(g) of IL-6R and gp130 protein expression in cultured hair cells. Actin expression was measured to check the quantity and integrity of the protein samples.
DP, dermal papilla; DS, dermal sheath; ORS, outer root sheath.
Figure 3. Immunohistochemical staining for IL-6R and gp130 in balding versus non-balding hair follicles. Matched balding (a and e) and non-balding (b and f)
scalp hair follicles were immunostained with antibodies against IL-6R (a and b) and gp130 (e and f). Close-up images of boxed regions of a, b, e, and f
with emphasis on the follicular matrix are also shown in c, d, g, and h. gp130, glycoprotein 130; IL-6R, IL-6 receptor.
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Ki-67-positive matrix cells around DP was markedly
decreased in the presence of 50 ngml1 of IL-6 (Figure 4b–d).
IL-6 treatment accelerates catagen onset from anagen in mice
To determine whether or not rhIL-6 induces premature
transition from anagen to catagen in vivo, the dorsal surfaces
of 5-week-old female C57BL/6 mice in the anagen stage of
the hair cycle (Mu¨ller-Ro¨ver et al., 2001) were shaved and
100ml of 500 ngml1 of rhIL-6 was injected once a day for
3 days. Histological examination of sections of the back skins
showed that hair follicles from the rhIL-6-injected skins
entered the catagen phase, whereas hair follicles from the
vehicle-treated skin remained in the anagen phase (Figure 5).
DISCUSSION
Although the underlying molecular, pathogenic mechanism
of male pattern baldness remains to be elucidated, recent
published data strongly suggest that inhibitory paracrine and
autocrine factors produced by the balding DP cells by DHT-
driven alterations may be key to male pattern baldness
(reviewed by Randall, 2008; Inui and Itami, 2011).
Specifically, transforming growth factors-b1/b2, which inhibit
epithelial cell growth, are increased from DP cells from the
balding scalp in response to androgens (Inui et al., 2002;
Hibino and Nishiyama, 2004), and DHT-inducible dickkopf 1
from balding DP cells causes apoptosis in follicular keratino-
cytes (Kwack et al., 2008). In addition, balding DP cells
secrete inhibitory autocrine factors that inhibit the growth of
DP cells (Hamada and Randall, 2006). With the hope of
identifying such paracrine and/or autocrine factors, in a
preliminary study we performed ELISA array screening and
found that higher levels of IL-6 are secreted from balding DP
cells compared with non-balding DP cells.
In this study, we observed that IL-6 mRNA and protein are
upregulated in six of seven (85%) and three of four (75%)
balding DP cells in male pattern baldness patients, respec-
tively. In addition, we observed that the level of expression of
IL-6 mRNA and protein was upregulated in response to DHT
in balding DP cells. This result is in agreement with the
finding that DHT increases IL-6 expression in SKOV-3
ovarian cancer cell lines (Wang et al., 2007). Further
investigation is needed to elucidate the mechanism of
DHT-induced IL-6 expression.
Previous studies have reported that IL-6 is expressed in the
DP and DS of human hair follicles and in cultured DP cells
and DS cells, whereas IL-6R and gp130 are expressed in the
inner and outer root sheaths of human hair follicles (Ahmed
et al., 1996; Chiu et al., 1996; Yu et al., 2008). In this study,
we also showed that IL-6R and gp130 are expressed in the
inner and outer root sheaths of human hair follicles.
However, in contrast to the reports of Yu et al. (2008) and
Ahmed et al. (1996), we observed that IL-6R and gp130 are
also expressed on matrix cells of hair follicles and in cultured
matrix cells. In agreement with this observation, we found a
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Figure 4. Effect of rhIL-6 on cultured human hair follicles. Isolated human
hair follicles were cultured for 6 days in the absence or presence of 5 or
50 ngml-1 recombinant human IL-6 (rhIL-6), and hair shaft elongation was
measured (a). Values are average of four mean±SD of six determinations per
experiment from four experiments (*Po0.05). Human hair follicles were
treated in the absence (c and e) or presence of 50 ngml1 rhIL-6 (d and f) for 2
days and stained with Ki-67 immunofluorescence staining. Corresponding
4,6-diamidino-2-phenylindole (DAPI) nuclear staining is also shown (e and f).
Ki-67-positive proliferative cells (red) in the hair bulb were counted and data
are mean±SD from five hair follicles (*Po0.05; b). Bar¼0.1mm.
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Figure 5. Effect of rhIL-6 on catagen onset. Scheme of the experiment (a).
The back skins of C57BL/6 mice (n¼ 6) were shaved at 5 weeks of age and the
vehicle (b) or 100 ml of 500 ngml1 of recombinant human IL-6 (rhIL-6; c) was
injected once a day for 3 days. The skin samples were stained with
hematoxylin and eosin and a representative histology is shown. The same
experiment was repeated twice using different mice. Bar¼ 0.1mm.
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significant reduction of Ki67-positive matrix cells and
inhibition of hair shaft elongation by IL-6 treatment in
cultured human hair follicles. These results strongly suggest
that IL-6 is released from DP cells and inhibits the activity of
follicular keratinocytes that express IL-6R in situ. However,
our finding is inconsistent with the report from Limat et al.
(1993), who found no correlation between outer root sheath
cell proliferation and IL-6 production in the coculture system,
and the report from Herna´ndez-Quintero et al. (2006), who
found promotion of human epidermal keratinocyte prolifera-
tion by IL-6. We suggest that the discrepancy is due to the
culture conditions or cell types used.
In developing male pattern baldness, hair follicles undergo
premature transition from anagen to catagen induced by
androgens (Jahoda, 1998), resulting in a short anagen phase.
Because we observed that IL-6 inhibits matrix cell prolifera-
tion, which expresses IL-6R resulting in hair shaft elongation
in cultured human hair follicles, we reasoned that IL-6
promotes anagen-to-catagen transition in vivo. Indeed, we
observed that IL-6 injection into the hypodermis during
anagen causes premature onset of catagen in mice. These
results, together with DHT-induced IL-6 expression in balding
DP cells, suggest that IL-6 is one of the paracrine factors from
DP, thereby shortening anagen hair growth (Figure 6).
Our finding of a hair growth-inhibitory action for IL-6 is in
agreement with the retarded hair growth in transgenic mice
that overexpress IL-6 under the control of keratin-14 promoter
(Turksen et al., 1992), and with the hair growth retardation in
mice receiving oncostatin M, an IL-6 cytokine family member
(Yu et al., 2008). Our data are also in agreement with the
recent report by Hamada and Randall (2006), who found that
conditioned medium of human balding DP cells delay the
onset of anagen in mice. However, our finding differs with
the recent report from Tanabe et al. (2006) who found a hair
growth-promoting effect of IL-6. Although further investiga-
tion is needed, we suggest that the discrepancy might be due
to the doses of IL-6 used.
In summary, we have provided evidence, which to our
knowledge is previously unreported, that balding DP cells
secrete higher levels of IL-6 compared with the non-balding
DP cells. We also have shown that IL-6 is inducible by DHT
in balding DP cells. In addition, IL-6 inhibits hair shaft
elongation and inhibits proliferation of matrix cells that
express IL-6R in cultured hair follicles. These data, together
with the early catagen induction effect of IL-6, strongly
suggest that DHT-inducible IL-6 inhibits hair growth as a
paracrine mediator from the DP.
MATERIALS AND METHODS
Isolation and culture of human hair follicles
Non-balding scalp specimens were obtained from patients under-
going hair transplantation surgery, and matching balding scalp
specimens were obtained by punch biopsy (3mm) from the same
individuals. The Medical Ethical Committee of the Kyungpook
National University Hospital (Daegu, Korea) approved all of the
described studies. The study was conducted according to the
Declaration of Helsinki Principles. Informed written consent was
obtained from the patients. Hair follicles from non-balding scalps
were used for organ culture studies. The hair follicles were isolated
and cultured as described before (Kwack et al., 2008).
Cell culture
DP and DS were isolated from the bulbs of the dissected hair
follicles, transferred onto plastic dishes coated with bovine type 1
collagen, and cultured in DMEM (Gibco BRL, Gaithersburg, MD),
supplemented with penicillin (100Uml1), streptomycin
(100mgml1), and 20% heat-inactivated fetal bovine serum at
37 1C in a humidified atmosphere of 5% CO2. The explants were left
for several days and the medium was changed every 3 days. After the
cell outgrowth became subconfluent, cells were harvested with
0.25% trypsin/10mM EDTA in Hanks’ balanced salt solution and
subcultured with a split ratio of 1:3. Subsequently, DP and DS
cells were maintained in DMEM supplemented with 10% fetal
bovine serum.
Matrix cells were isolated and cultured as described before (Roh
et al., 2004). Briefly, hair follicles at anagen phase were selected,
and matrix cell-containing tissue fragments were dissected out. Hair
fragments were digested with 0.05% trypsin–EDTA for 10minutes,
and Versene (0.53mM, Gibco BRL) was added for an additional
10minutes. Cells were centrifuged and plated onto tissue culture
plastic dishes. The isolated cells were then cultured in keratinocyte
growth medium on a feeder layer of NIH3T3 fibroblasts that had
been pretreated with mitomycin C for 2 hours. Outer root sheath
cells were cultured as described before (Kwack et al., 2008). Briefly,
the hair shaft and hair bulb regions of the hair follicle were cut off to
prevent contamination with other cells. Trimmed hair follicles were
immersed in DMEM supplemented with 20% fetal bovine serum. On
the third day of culture, the medium was changed to keratinocyte
growth medium containing penicillin, streptomycin, and fungizone.
DHT
IL-6
Matrix cell
Anagen hair growth
(shaft elongation)
Matrix cell
proliferation
IL-6
Dermal papilla
Figure 6. Proposed model based on this study. Dihydrotestosterone (DHT)-
inducible IL-6 from dermal papilla functions as an inhibitory paracrine
mediator that inhibits hair shaft growth by suppressing matrix cell
proliferation.
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Reverse transcription-PCR analysis
Total RNA was isolated using TRIzol reagent and complementary
DNA was synthesized from 3 mg of total RNA using the comple-
mentary DNA synthesis kit containing the ImProm-IITM reverse
transcriptase and oligo-dT primer, according to the instructions of
the manufacturer (Promega, Madison, WI). Complementary DNA
(1ml) was amplified with each of the forward and reverse primers.
For the detection of IL-6, 30 cycles (45 seconds at 94 1C, 45 seconds
at 56 1C, and 45 seconds at 72 1C) of amplification were performed
with forward primer 50-TACCCCCAGGAGAAGATTCC-30 and re-
verse primer 50-GAGGTGCCCATGCTACATTT-30. For the detection
of b-actin, 23 cycles (45 seconds at 94 1C, 45 seconds at 58 1C, and
45 seconds at 72 1C) of amplification was performed with 50-GGGAA
ATCGTGCGTGACATT-30 and 50-GGAGTTGAAGGTAGTTTCGT-30.
PCR products were separated by electrophoresis on a 1% agarose gel
and visualized under UV light.
ELISA
An IL-6 ELISA kit (R&D Systems, Minneapolis, MN) was used
according to the manufacturer’s protocol. For the measurement of IL-
6 levels in conditioned medium of balding and non-balding DP
cells, cells from passages 2–3 were plated overnight at a density of
300,000 cells per 100mm culture dish, washed three times with
phosphate-buffered saline (PBS), and then incubated in serum-free
medium for 24 hours for the collection of conditioned medium. To
examine IL-6 induction in response to DHT in balding DP cells,
cells were treated with varying concentrations of DHT in serum-
free medium for 24 hours and concentrations of IL-6 in conditioned
medium were measured. Briefly, 50 ml of culture conditioned
medium was loaded per well on titer plates coated with IL-6
antibody and incubated at 4 1C for 2 hours, washed, and incubated
with IL-6 conjugate at 4 1C for 2 hours. Further, 200 ml of substrate
solution was added and incubated for 30minutes at room
temperature. Optical density was measured by an ELISA reader at
450 nm. Serial dilutions of rhIL-6 were used to establish a standard
curve.
Immunoblotting
Total cell lysates (5mg per lane) were separated by 10% SDS-PAGE,
and then transferred to nitrocellulose membranes. The membranes
were blocked with 5% milk in PBS for 1 hour, and probed with rabbit
polyclonal antibodies against IL-6R (1:1,000 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA) and gp130 (1:1,000 dilution; Santa
Cruz Biotechnology) at 4 1C overnight. Horseradish peroxidase-
conjugated donkey anti-rabbit Ig (Zymed Laboratories, San Francisco,
CA) was used as the secondary antibody at a 1:7,000 dilution. The
bands were visualized using ECL Plus (Amersham, Buckinghamshire,
UK). The membranes were also probed with mouse mAb against
actin (Chemicon, Temecula, CA).
Immunohistochemistry and immunofluorescence staining
Hair follicle specimens were placed in cryomolds using embedding
medium (OCT compound, Tissue-Tek; Miles, Napierville, IL) in a
freezer at 80 1C. The tissue block was cut into sections (7mm thick)
using a cryostat (Leica CM3050 S; Heidelberg, Germany) and
sections were applied on glass slides. Tissue sections were fixed with
4% paraformaldehyde containing 0.1% Triton X-100 for 10minutes
and equilibrated in PBS for 15minutes at room temperature. After
blocking with 4% normal donkey serum (Jackson ImmunoResearch,
West Grove, PA) for 1 hour at room temperature, sections were
incubated with IL-6R (1:50 dilution) and gp130 (1:50 dilution) at
4 1C overnight, washed three times with PBS, incubated with
secondary antibody-horseradish peroxidase-conjugated antibody
for 1 hour, and rinsed again with PBS. AEC (DAKO, Glostrup,
Denmark) was used as a color-developing reagent for horseradish
peroxidase, and the slides were counterstained with hematoxylin.
For immunofluorescence staining of Ki-67, fixation and blocking
procedures were performed as above. Sections were incubated with
Ki-67 antibody (1:100 dilution; Becton Dickinson, Franklin, NJ) at
4 1C overnight, washed three times with PBS, and incubated with
Alexa Flour 555-labeled donkey anti-mouse secondary antibody
(Molecular Probes, Eugene, OR) for 1 hour. The slides were then
washed with PBS and counterstained with 4,6-diamidino-2-phenyl-
indole for 10minutes.
In vivo study
Five-week-old female C57BL/6 mice in the anagen stage of the hair
cycle (Mu¨ller-Ro¨ver et al., 2001) were purchased from Orient Bio
(Seongnam, Korea). After 1 day, the dorsal areas of each mouse were
shaved with clippers and 500ngml1 of rhIL-6 in 100ml of PBS was
administered subcutaneously for 3 days. Further, mice were killed
and the treated region of the dorsal skin was stained with
hematoxylin and eosin.
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